UnitedHealth Group Incorporated $UNH Shares Bought by Factory Mutual Insurance Co.

Key Points

• Factory Mutual Insurance increased its UnitedHealth stake by 4.4% in the third quarter, adding 11,466 shares to bring its holding to 273,616 shares, valued at about $100.4 million.
• UnitedHealth reported quarterly EPS of $4.69, beating the $4.14 consensus, and revenue of $112.72 billion, above estimates; revenue was down 0.4% year over year.
• Analysts maintain a “Moderate Buy” consensus on UNH, with an average price target of $463.93. The company’s quarterly dividend equates to $9.28 annually, a 2.3% yield at the article’s cited share price.

Factory Mutual Insurance Co. boosted its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 4.4% in the third quarter, according to its most recent disclosure with the SEC. The firm owned 273,616 shares of the healthcare conglomerate's stock after acquiring an additional 11,466 shares during the period. UnitedHealth Group comprises about 0.9% of Factory Mutual Insurance Co.'s holdings, making the stock its 27th biggest holding. Factory Mutual Insurance Co.'s holdings in UnitedHealth Group were worth $100,439,000 as of its most recent filing with the SEC.

Several other institutional investors have also modified their holdings of UNH. Nvwm LLC lifted its stake in UnitedHealth Group by 89.2% in the 3rd quarter. Nvwm LLC now owns 70 shares of the healthcare conglomerate's stock valued at $26,000 after buying an additional 33 shares in the last quarter. Wellington Altus USA Inc. boosted its holdings in UnitedHealth Group by 97.1% in the 2nd quarter. Wellington Altus USA Inc. now owns 67 shares of the healthcare conglomerate's stock worth $28,000 after buying an additional 33 shares during the last quarter. Security National Bank of SO Dak purchased a new stake in UnitedHealth Group during the 2nd quarter worth approximately $29,000. Compass Wealth Management LLC acquired a new position in shares of UnitedHealth Group during the third quarter valued at approximately $29,000. Finally, Aberdeen Wealth Management LLC purchased a new position in shares of UnitedHealth Group in the second quarter valued at approximately $31,000. Institutional investors and hedge funds own 87.86% of the company's stock.

UnitedHealth Group Trading Up 0.7%

Shares of UnitedHealth Group stock opened at $403.10 on Wednesday. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.74 and a quick ratio of 0.78. The stock's 50 day simple moving average is $390.47 and its 200-day simple moving average is $363.08. The stock has a market cap of $361.81 billion, a P/E ratio of 23.02, a P/E/G ratio of 1.45 and a beta of 0.51. UnitedHealth Group Incorporated has a 1-year low of $255.96 and a 1-year high of $461.62.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings results on Tuesday, October 13th. The healthcare conglomerate reported $4.69 EPS for the quarter, beating the consensus estimate of $4.14 by $0.55. UnitedHealth Group had a return on equity of 17.95% and a net margin of 3.53%. The firm had revenue of $112.72 billion during the quarter, compared to analysts' expectations of $111.31 billion. During the same quarter last year, the firm earned $2.59 earnings per share. The business's revenue for the quarter was down .4% on a year-over-year basis. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. Analysts predict that UnitedHealth Group Incorporated will post 20.61 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, September 22nd. Shareholders of record on Monday, September 14th were paid a $2.32 dividend. The ex-dividend date of this dividend was Monday, September 14th. This represents a $9.28 dividend on an annualized basis and a dividend yield of 2.3%. UnitedHealth Group's dividend payout ratio (DPR) is 53.00%.

Key Headlines Impacting UnitedHealth Group

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Earnings and outlook are key tailwinds. UnitedHealth’s quarterly EPS and revenue beat analysts’ estimates, and the company raised its 2026 profit outlook. Those results helped drive an approximately 11% share gain over the month through October 30. UnitedHealth Just Gained 11% in a Month: Take Profits, or Buy More?
• Positive Sentiment: Buying and value-oriented endorsements provide support. ETFs recorded net purchases of UnitedHealth shares, including $35 million in buying on October 29. BetterInvesting Magazine also named UNH its “Undervalued Stock,” though such selections are not a guarantee of future performance. UnitedHealth Group Draws ETF Buying BetterInvesting Magazine Update
• Neutral Sentiment: Optum Insight’s AI investment is a longer-term opportunity with execution risk. UnitedHealth is expanding AI tools to improve efficiency and claims processing, but rising costs mean the spending still needs to translate into profit growth. Will UNH’s Optum Insight Spending Translate Into Profit Growth?
• Negative Sentiment: Political scrutiny could weigh on sentiment. Senator Elizabeth Warren criticized the Trump administration’s approval of UnitedHealth’s $3.3 billion Amedisys acquisition, arguing the deal increases the company’s power over costs and patient care. The comments renew attention to potential regulatory and political risks. Elizabeth Warren Criticizes UnitedHealth’s Amedisys Deal

Insider Activity at UnitedHealth Group

In other news, CEO Patrick Conway sold 1,169 shares of UnitedHealth Group stock in a transaction on Friday, August 21st. The stock was sold at an average price of $390.00, for a total transaction of $455,910.00. Following the transaction, the chief executive officer owned 15,328 shares in the company, valued at $5,977,920. The trade was a 7.09% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 0.19% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

A number of brokerages have recently issued reports on UNH. TD Cowen reaffirmed a "hold" rating and issued a $402.00 price target on shares of UnitedHealth Group in a research note on Thursday, October 15th. HC Wainwright set a $500.00 price objective on UnitedHealth Group in a research note on Friday, October 16th. Jefferies Financial Group raised their price objective on UnitedHealth Group from $401.00 to $490.00 and gave the company a "buy" rating in a report on Friday, July 17th. Stephens set a $500.00 target price on shares of UnitedHealth Group in a research note on Friday, October 16th. Finally, UBS Group reaffirmed an "outperform" rating on shares of UnitedHealth Group in a report on Tuesday, October 13th. Twenty investment analysts have rated the stock with a Buy rating and eight have given a Hold rating to the stock. Based on data from MarketBeat.com, UnitedHealth Group presently has a consensus rating of "Moderate Buy" and a consensus target price of $463.93.

About UnitedHealth Group

UnitedHealth Group Incorporated NYSE: UNH is a diversified health care company that provides health insurance coverage, health care services, pharmacy services and health technology. Its businesses serve individuals, employers, government programs, health care providers and other organizations, primarily in the United States.

The company operates through two principal businesses. UnitedHealthcare offers health benefit plans and related services for employers, individuals, families and government-sponsored programs, including Medicare and Medicaid.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.